EAU YAU Urothelial Carcinoma(@EAU_YAUrotheli) 's Twitter Profileg
EAU YAU Urothelial Carcinoma

@EAU_YAUrotheli

YAU Urothelial Carcinoma WorkingGroup focus to produce researches on #Bladdercancer and #UTUC from @uroweb

ID:1463865877565222924

calendar_today25-11-2021 13:43:54

90 Tweets

476 Followers

228 Following

Andrea Gallioli(@agallioli) 's Twitter Profile Photo

This was full of unbelievable experiences such as live surgery & abstract session moderations, the opportunity of new collaborations & the celebration of long-term friendships!!!

See you in Madrid 🇪🇸

This #EAU24 was full of unbelievable experiences such as live surgery & abstract session moderations, the opportunity of new collaborations & the celebration of long-term friendships!!! See you in Madrid 🇪🇸 #EAU25
account_circle
Jeremy Teoh(@jteoh_hk) 's Twitter Profile Photo

The Global En Bloc Resection of Bladder Tumour Registry meeting will be held at 3:30pm on 6th April, Meeting Room 8. Please come if you are interested to join the study!

The Global En Bloc Resection of Bladder Tumour Registry meeting will be held at 3:30pm on 6th April, Meeting Room 8. Please come if you are interested to join the study! #EAU24 #ERBT
account_circle
Tom Powles(@tompowles1) 's Twitter Profile Photo

Enfortumab + Pembro outperforms platinum chemotherapy in advanced UC with a doubling of PFS and a halving of the risk of death @nejm. G3/4 AEs of 56% for EVP vs 70% for chemo & CR=29%. Editorial by @gniegisch ‘EVP is the new standard against which future trials must be compared’

Enfortumab + Pembro outperforms platinum chemotherapy in advanced UC with a doubling of PFS and a halving of the risk of death @nejm. G3/4 AEs of 56% for EVP vs 70% for chemo & CR=29%. Editorial by @gniegisch ‘EVP is the new standard against which future trials must be compared’
account_circle
European Association of Urology (EAU)(@Uroweb) 's Twitter Profile Photo

⏰HOT OF THE PRESS 📰
Yesterday at @esmo, the future of patients who suffer from metastatic dramatically changed! 🤩 Tom Powles presented amazing results from EV-302.

🎧Listen to his interview with Benjamin Pradere to hear more👉 ow.ly/czyw50PZweL

⏰HOT OF THE PRESS 📰 Yesterday at #ESMO2023 @esmo, the future of patients who suffer from metastatic #BladderCancer dramatically changed! 🤩 @tompowles1 presented amazing results from EV-302. 🎧Listen to his interview with @BenjaminPradere to hear more👉 ow.ly/czyw50PZweL
account_circle
Benjamin Pradere(@BenjaminPradere) 's Twitter Profile Photo

🥹 what a 💥 from Tom Powles
The most impactful study of the last 20 years for mUC
EV-Pembro improved OS + PFS of almost 50% w/ a impressive OS HR=0.47
🍒on the🧁➡️ the benefit is seen in all subgroups 🥹
⛑️Safety: TRAES 27%

🤩so much hope for our patients🙏

A NEW SOC is BORN

🥹 what a 💥 from @tompowles1 The most impactful study of the last 20 years for mUC EV-Pembro improved OS + PFS of almost 50% w/ a impressive OS HR=0.47 🍒on the🧁➡️ the benefit is seen in all subgroups 🥹 ⛑️Safety: TRAES 27% 🤩so much hope for our patients🙏 A NEW SOC is BORN
account_circle
Luca Afferi(@Luca_Afferi) 's Twitter Profile Photo

Extremely happy having Dr. Andrea Gallioli from Fundació Puigvert visiting our Urology department Luzerner Kantonsspital and talking about conservative management of UTUC. Sharing experience is so important for such an uncommon condition!

Extremely happy having Dr. @agallioli from @FPuigvert visiting our Urology department @KantonsspitalLU and talking about conservative management of UTUC. Sharing experience is so important for such an uncommon condition!
account_circle
Benjamin Pradere(@BenjaminPradere) 's Twitter Profile Photo

What a great time in to discuss the updates in Bladder Cancer with my 🇮🇹friends and colleagues! Insightful debates and fantastic organisation
Thank you for the invitation Paolo Gontero francesco soria !
I will come back w/pleasure!
EAU YAU Urothelial Carcinoma

What a great time in #Torino to discuss the updates in Bladder Cancer with my 🇮🇹friends and colleagues! Insightful debates and fantastic organisation Thank you for the invitation @paolo_gontero @frasor86 ! I will come back w/pleasure! @EAU_YAUrotheli
account_circle
Benjamin Pradere(@BenjaminPradere) 's Twitter Profile Photo

Last week I was Antoni van Leeuwenhoek 🇳🇱 with a fantastic UroOnco team! Great exchange, clinical cases and research projects! A terrific team full of ⚡️energy!
Best is to come!
Thx for the invitation Laura S. Mertens Dr Van Rhijn Oscar Brouwer henk van der poel Maaike Van De Kamp Erik van Muilekom

Last week I was @hetAVL 🇳🇱 #amsterdam with a fantastic UroOnco team! Great exchange, clinical cases and research projects! A terrific team full of ⚡️energy! Best is to come! Thx for the invitation @LAUrology_NL Dr Van Rhijn @Brouwer_MD_PhD @hvdpoel @vandekampmw @ErikvanMuilekom
account_circle
Jeremy Teoh(@jteoh_hk) 's Twitter Profile Photo

What a great pleasure to have a prestigious panel of authors and pioneers in the field, to contribute this important paper to @WJUrol, about the history and development as well as the future directions of en bloc resection of bladder tumour. (1/n)

What a great pleasure to have a prestigious panel of authors and pioneers in the field, to contribute this important paper to @wjurol, about the history and development as well as the future directions of en bloc resection of bladder tumour. #EBRT #UroSoMe (1/n)
account_circle
Jeremy Teoh(@jteoh_hk) 's Twitter Profile Photo

Three RCTs reported the results recently. The study by Andrea Gallioli Alberto Breda (n=300) showed that the rate of DM for ERBT was noninferior to that for TURBT (94% vs 95%). At a median follow-up of 15m, the recurrence rate was 13% for ERBT and 18% for TURBT (p=0.16). (6/n)

Three RCTs reported the results recently. The study by @agallioli @AlbertoBreda1 (n=300) showed that the rate of DM for ERBT was noninferior to that for TURBT (94% vs 95%). At a median follow-up of 15m, the recurrence rate was 13% for ERBT and 18% for TURBT (p=0.16). (6/n)
account_circle